Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
daily or weekly) to correct deficiency, followed by maintenance (commonly 1 mg IM monthly or as prescribed)
Mechanism of Action: A Multimodal Cellular Signaling Profile One of the most distinctive features of BPC-157 from a pharmacological research perspective is the absence of a single, well-characterized primary receptor target
Nguyen T, Nioi P, Pickett CB
Sample COAs can also be viewed in our COA library before you buy, so you can review our testing standards in advance
Diabetes should be well-managed before starting therapy Active pituitary tumors: Stimulating a gland with an active tumor is contraindicated Monitoring Requirements Safe use of CJC-1295/Ipamorelin requires ongoing physician monitoring: Baseline labs: IGF-1, fasting glucose, HbA1c, thorough metabolic panel, CBC 4-6 week follow-up: IGF-1 to confirm dose response
